Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of January 24, 2021
Diffuse large B cell lymphoma gets new first line therapy
From the Gopal laboratory, Clinical Research Division, and the Smith laboratory, University of Washington Medical Oncology
One family, two sides of cancer
Basic scientist Dr. Wenying Shou’s parents were both treated for — and cured of — their cancers. The similarities end there.
Paulovich Lab's proteomic platform presented at personalized medicine conference
Celebrating faculty and staff achievements
Fred Hutch at ASCO
Research highlights from the annual meeting of the American Society of Clinical Oncology
New drug shows promise in treating slow-growing non-Hodgkin lymphomas
Idelalisib could be on the market later this year, pending FDA approval
New drug shows promise in treating indolent non-Hodgkin lymphomas - Fred Hutchinson Cancer Research Center
Idelalisib could be on the market later this year, pending FDA approval
High-dose Vorinostat effective at treating relapsed lymphomas
First-of-its-kind clinical trial by Fred Hutchinson Cancer Research Center’s Dr. Ajay Gopal and colleagues sets stage for new class of drugs to treat aggressive blood cancer and sensitize tumors to chemotherapy
High-dose Vorinost effective treating lymphomas - Fred Hutchinson Cancer Research Center
Results of phase 1 clinical trial lead way to use of new class of drugs to treat aggressive blood cancer
ASH lauds Cassaday’s abstract
Fred Hutch Clinical Research fellow Ryan Cassaday honored by American Society of Hematology for mantle cell lymphoma research
Less toxic treatment for non-Hodgkins lymphoma
Ajay Gopal finds targeted radiation a safer more effective treatment for older patients
Precision punch to lymphoma
Ajay Gopal and colleagues use antibodies to deliver targeted, less toxic treatment to lymphoma's most vulnerable victims